E-ISSN: 1308-5263
Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia [Turk J Hematol]
Turk J Hematol. 2020; 37(3): 208-209 | DOI: 10.4274/tjh.galenos.2020.2019.0180  

Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia

Gülşen İskender1, Dicle İskender2, Mustafa Ertek1
1Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Ankara, Turkey
2Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology and Blood and Marrow Transplantation, Ankara, Turkey

Keywords: Hepatitis B reactivation, Ibrutinib, Chronic lymphocytic leukemia


Kronik Lenfositik Lösemili Bir Hastada İbrutinib Tedavisi Altında Hepatit B Virüsü Reaktivasyonu

Gülşen İskender1, Dicle İskender2, Mustafa Ertek1
1Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Ankara, Turkey
2Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology and Blood and Marrow Transplantation, Ankara, Turkey

Anahtar Kelimeler: Hepatit B reaktivasyonu, İbrutinib, Kronik lenfositik lösemi


Gülşen İskender, Dicle İskender, Mustafa Ertek. Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia. Turk J Hematol. 2020; 37(3): 208-209

Corresponding Author: Gülşen İskender


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar


 



Impact Factor (2019) = 1.685